急性肾损伤
未折叠蛋白反应
HDAC6型
药理学
医学
化学
生物化学
内科学
内质网
组蛋白脱乙酰基酶
基因
组蛋白
作者
Shuyan Kan,Qing Hou,Ruixiang Yang,Fan Yang,Mingchao Zhang,Zhihong Liu,Song Jiang
标识
DOI:10.1016/j.abb.2024.110009
摘要
Histone deacetylase 6 (HDAC6) inhibitor CAY10603 has been identified as a potential therapeutic agent for the treatment of diabetic kidney disease (DKD). The objective of this study was to investigate the therapeutic effects of CAY10603 in mice with acute kidney injury (AKI) and chronic kidney diseases (CKD).
科研通智能强力驱动
Strongly Powered by AbleSci AI